'Insignificant' prostate cancer on prostatectomy and cystoprostatectomy: variation on a theme 'low-volume/low-grade' prostate cancer?

BJU International
Kiril TrpkovRodolfo Montironi

Abstract

Although 'insignificant' prostate cancer has been examined separately in radical prostatectomy (RP) and radical cystoprostatectomy (RCP) studies, it is not entirely clear whether cancers designated as 'insignificant' on RP and RCP represent the same, similar or different forms of prostate cancer. Insignificant prostate cancer has been traditionally defined based on the pathological findings in the whole prostate gland. In addition to the pathological determinants of 'insignificant' prostate cancer, it is also important to account for the biological and the clinical context of the disease, as well as patient age and health status to designate a prostate cancer 'insignificant'. This review examines and compares prostate cancers described as 'insignificant' on RP and RCP. We conclude that in most cases these low-volume/low-grade prostate cancers represent an early stage and clinically 'silent' disease, which are only detected in different clinical settings.

References

Feb 2, 1994·JAMA : the Journal of the American Medical Association·J I EpsteinC B Brendler
May 1, 1993·The American Journal of Surgical Pathology·P A Humphrey
Jan 24, 1996·JAMA : the Journal of the American Medical Association·J A DuganJ E Oesterling
May 1, 1996·British Journal of Urology·V RaveryL Boccon-Gibod
Jan 1, 1996·European Urology·W A SakrJ D Crissman
Jun 1, 1997·The Journal of Urology·H B CarterJ I Epstein
Nov 26, 1999·Scandinavian Journal of Urology and Nephrology. Supplementum·T Nevéus
Apr 12, 2000·BJU International·C BrössnerA Pycha
May 8, 2001·American Journal of Clinical Pathology·P Thorson, P A Humphrey
Jan 17, 2002·The Journal of Urology·Gerald W HullPeter T Scardino
Jul 4, 2002·Journal of the National Cancer Institute·Ruth EtzioniEric J Feuer
Jul 13, 2004·The Journal of Urology·Eiji KikuchiMakoto Ohori
Sep 17, 2004·Cancer·Eric A Klein
Apr 15, 2005·International Journal of Urology : Official Journal of the Japanese Urological Association·Hideaki MiyakeHiroshi Eto

❮ Previous
Next ❯

Citations

Oct 31, 2013·Annals of Surgical Oncology·Géraldine PignotUNKNOWN Oncologic Committee of the French Association of Urology
Feb 3, 2016·Der Urologe. Ausg. A·Annika Herlemann, Christian G Stief
May 24, 2011·European Urology·Guillaume PloussardTheodorus H van der Kwast
Jan 7, 2014·Prostate International·Seung Hwan LeeByung Ha Chung
Jul 26, 2011·Urologia·Andrea Vismara FuginiSergio Cosciani Cunico
Apr 7, 2017·International Journal of Surgical Pathology·Emily R FilterMadeleine Moussa
Apr 2, 2011·Current Opinion in Urology

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.